Hinge Health Stock Soars 10.27% on Strong Q2 Earnings

Hinge Health's stock surged 10.27% in pre-market trading on August 6, 2025, reflecting strong investor confidence in the company's recent performance and future prospects.

Hinge Health reported impressive financial results for the second quarter of 2025, with revenue increasing by 55% year-over-year to $139.1 million. This significant growth was driven by a 32% expansion in its client base, reaching 2,359 clients as of June 30, 2025. The company's AI-powered platform has been well-received by the market, contributing to its strong free cash flow margin and operational discipline.

The company's gross margins also showed notable improvements, with a GAAP gross margin of 70% and a non-GAAP gross margin of 83%. Additionally, Hinge Health provided optimistic revenue guidance for the third quarter and full year 2025, indicating continued growth and market penetration.

Investment firms have responded positively to Hinge Health's performance, with Stifel raising its 2025 revenue growth estimate from 35% to 42% and increasing its EBIT margin forecast from 7.4% to 15%. Citizens JMP also raised its price target on Hinge Health to $65.00, reflecting the company's strong financial performance and market potential.